{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:09:34Z","timestamp":1760609374047,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200085"],"award-info":[{"award-number":["81200085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.peptides.2021.170609","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T11:01:00Z","timestamp":1625569260000},"page":"170609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Urotensin II induces activation of NLRP3 and pyroptosis through calcineurin in cardiomyocytes"],"prefix":"10.1016","volume":"144","author":[{"given":"Yanyan","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengdan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2021.170609_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.peptides.2021.170609_bib0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"Hunt","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2021.170609_bib0015","first-page":"e841","article-title":"American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics-2013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2021.170609_bib0020","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.peptides.2021.170609_bib0025","first-page":"2388","volume":"29","author":"Dickstein","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.peptides.2021.170609_bib0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-2407-10-105","article-title":"Long-term survival of cancer patients compared to heart failure and stroke: a systematic review","volume":"10","author":"Askoxylakis","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.peptides.2021.170609_bib0035","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nature15632","article-title":"Immunology: caspase target drives pyroptosis","volume":"526","author":"Broz","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2021.170609_bib0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasomeactivated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2021.170609_bib0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases","volume":"277","author":"Man","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.peptides.2021.170609_bib0050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jhep.2015.04.010","article-title":"Heatstroke induces liver injury via IL-1beta and HMGB1-induced pyroptosis","volume":"63","author":"Geng","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.peptides.2021.170609_bib0055","doi-asserted-by":"crossref","first-page":"84658","DOI":"10.18632\/oncotarget.12384","article-title":"Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma","volume":"7","author":"Chu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.peptides.2021.170609_bib0060","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","article-title":"MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.peptides.2021.170609_bib0065","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171438","article-title":"Caspase-1 regulate AngII-induced cardiomyocyte hypertrophy via upregulation of IL-1beta","volume":"38","author":"Bai","year":"2018","journal-title":"Bioscience reports"},{"key":"10.1016\/j.peptides.2021.170609_bib0070","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","article-title":"MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.peptides.2021.170609_bib0075","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1073\/pnas.77.8.5021","article-title":"Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes","volume":"77","author":"Pearson","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.peptides.2021.170609_bib0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/45809","article-title":"Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14","volume":"401","author":"Ames","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2021.170609_bib0085","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.drudis.2019.08.005","article-title":"Novel insights into the role of urotensin II in cardiovascular disease","volume":"24","author":"Pereira-Castro","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.peptides.2021.170609_bib0090","doi-asserted-by":"crossref","first-page":"H925","DOI":"10.1152\/ajpheart.2001.280.2.H925","article-title":"Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries","volume":"280","author":"Stirrat","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"10.1016\/j.peptides.2021.170609_bib0095","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/S0014-2999(00)00506-9","article-title":"Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries","volume":"402","author":"Katano","year":"2000","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.peptides.2021.170609_bib0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/15321819.2017.1344130","article-title":"The role of human urotensin-II in patients with hypertrophic cardiomyopathy","volume":"39","author":"Jumaah","year":"2018","journal-title":"J Immuno. Immunochem"},{"key":"10.1016\/j.peptides.2021.170609_bib0105","first-page":"7","article-title":"Clinical Significance of Increased Urotensin II Levels in Acute Myocardial Infarction","volume":"26","author":"Zhang","year":"2018","journal-title":"Discov Med"},{"key":"10.1016\/j.peptides.2021.170609_bib0110","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/HYPERTENSIONAHA.111.173500","article-title":"Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy","volume":"58","author":"Zou","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2021.170609_bib0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/hc2601.090987","article-title":"Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin","volume":"104","author":"Zou","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2021.170609_bib0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.4017","article-title":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis","volume":"22","author":"Zhang","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.peptides.2021.170609_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yjmcc.2019.08.009","article-title":"Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3","volume":"136","author":"Meng","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.peptides.2021.170609_bib0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41401-019-0305-x","article-title":"\u03b11-AR overactivation induces cardiac inflammation through NLRP3 inflammasome activation","volume":"41","author":"Xin","year":"2020","journal-title":"Acta Pharmacol Sin."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:29:33Z","timestamp":1759310973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978121001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":26,"alternative-id":["S0196978121001170"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170609","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urotensin II induces activation of NLRP3 and pyroptosis through calcineurin in cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"170609"}}